https://edgen.beta.edgen.tech/news/post/uganda-holds-key-rate-at-975-as-iran-war-clouds-outlook2026-05-14T12:32:15.481Zdaily1Edgen Stocken2026-05-14T12:32:15.481+00:00Uganda holds key rate at 9.75% as Iran war clouds outlookhttps://static.edgen.tech/news/images/uganda-holds-key-rate-at-975-as-iran-war-clouds-outlook-20260514.pngUganda holds key rate at 9.75% as Iran war clouds outlook https://edgen.beta.edgen.tech/news/post/graphon-ai-gets-83-million-to-lighten-the-load-on-ai-models2026-05-14T12:19:10.271Zdaily1Edgen Stocken2026-05-14T12:19:10.271+00:00Graphon AI gets $8.3 million to lighten the load on AI modelshttps://static.edgen.tech/news/images/graphon-ai-gets-83-million-to-lighten-the-load-on-ai-models-20260514.pngGraphon AI gets $8.3 million to lighten the load on AI models https://edgen.beta.edgen.tech/news/post/gds-stock-surges-7-on-ai-hype-but-valuation-is-stretched2026-05-14T12:15:34.072Zdaily1Edgen Stocken2026-05-14T12:15:34.072+00:00GDS Stock Surges 7% on AI Hype but Valuation Is Stretchedhttps://static.edgen.tech/news/images/gds-stock-surges-7-on-ai-hype-but-valuation-is-stretched-20260514.pngGDS Stock Surges 7% on AI Hype but Valuation Is Stretched https://edgen.beta.edgen.tech/news/post/celcuity-expands-gedatolisib-trial-to-90000-patients-in-first-line-breast-cancer2026-05-14T12:15:21.251Zdaily1Edgen Stocken2026-05-14T12:15:21.251+00:00Celcuity Expands Gedatolisib Trial to 90,000 Patients in First-Line Breast Cancerhttps://static.edgen.tech/news/images/celcuity-expands-gedatolisib-trial-to-90000-patients-in-first-line-breast-cancer-20260514.pngCelcuity Expands Gedatolisib Trial to 90,000 Patients in First-Line Breast Cancer https://edgen.beta.edgen.tech/news/post/klarna-stock-jumps-6-after-q1-revenue-beats-estimates2026-05-14T12:08:36.677Zdaily1Edgen Stocken2026-05-14T12:08:36.677+00:00Klarna Stock Jumps 6% After Q1 Revenue Beats Estimateshttps://static.edgen.tech/news/images/klarna-stock-jumps-6-after-q1-revenue-beats-estimates-20260514.pngKlarna Stock Jumps 6% After Q1 Revenue Beats Estimates https://edgen.beta.edgen.tech/news/post/why-a-50-grid-investment-hike-is-the-new-energy-logic2026-05-14T12:00:54.120Zdaily1Edgen Stocken2026-05-14T12:00:54.120+00:00Why a 50% grid investment hike is the new energy logichttps://static.edgen.tech/news/images/why-a-50-grid-investment-hike-is-the-new-energy-logic-20260514.pngWhy a 50% grid investment hike is the new energy logic https://edgen.beta.edgen.tech/news/post/watches-of-switzerland-jumps-14-as-us-sales-top-1-billion2026-05-14T11:50:11.767Zdaily1Edgen Stocken2026-05-14T11:50:11.767+00:00Watches of Switzerland Jumps 14% as US Sales Top £1 Billionhttps://static.edgen.tech/news/images/watches-of-switzerland-jumps-14-as-us-sales-top-1-billion-20260514.pngWatches of Switzerland Jumps 14% as US Sales Top £1 Billion https://edgen.beta.edgen.tech/news/post/ionis-jumps-8-as-alzheimers-drug-is-first-to-show-cognitive-gain2026-05-14T11:48:18.730Zdaily1Edgen Stocken2026-05-14T11:48:18.730+00:00Ionis Jumps 8% as Alzheimer's Drug Is First to Show Cognitive Gainhttps://static.edgen.tech/news/images/ionis-jumps-8-as-alzheimers-drug-is-first-to-show-cognitive-gain-20260514.pngIonis Jumps 8% as Alzheimer's Drug Is First to Show Cognitive Gain https://edgen.beta.edgen.tech/news/post/inpex-faces-strike-at-93m-ton-lng-plant-as-talks-end2026-05-14T11:46:54.863Zdaily1Edgen Stocken2026-05-14T11:46:54.863+00:00Inpex faces strike at 9.3m-ton LNG plant as talks endhttps://static.edgen.tech/news/images/inpex-faces-strike-at-93m-ton-lng-plant-as-talks-end-20260514.pngInpex faces strike at 9.3m-ton LNG plant as talks end https://edgen.beta.edgen.tech/news/post/3-us-telecom-giants-forge-satellite-venture-to-end-dead-zones2026-05-14T11:45:30.881Zdaily1Edgen Stocken2026-05-14T11:45:30.881+00:003 US Telecom Giants Forge Satellite Venture to End Dead Zoneshttps://static.edgen.tech/news/images/3-us-telecom-giants-forge-satellite-venture-to-end-dead-zones-20260514.png3 US Telecom Giants Forge Satellite Venture to End Dead Zones https://edgen.beta.edgen.tech/news/post/cabaletta-posts-50-response-rate-in-pc-free-car-t-study2026-05-14T11:41:42.082Zdaily1Edgen Stocken2026-05-14T11:41:42.082+00:00Cabaletta posts 50% response rate in PC-free CAR-T studyhttps://static.edgen.tech/news/images/cabaletta-posts-50-response-rate-in-pc-free-car-t-study-20260514.pngCabaletta posts 50% response rate in PC-free CAR-T study https://edgen.beta.edgen.tech/news/post/regenxbio-gene-therapy-hits-93-expression-in-trial-challenging-rival2026-05-14T11:41:20.105Zdaily1Edgen Stocken2026-05-14T11:41:20.105+00:00Regenxbio Gene Therapy Hits 93% Expression in Trial, Challenging Rivalhttps://static.edgen.tech/news/images/regenxbio-gene-therapy-hits-93-expression-in-trial-challenging-rival-20260514.pngRegenxbio Gene Therapy Hits 93% Expression in Trial, Challenging Rival https://edgen.beta.edgen.tech/news/post/healthcare-triangle-revenue-soars-166-after-ai-driven-acquisitions2026-05-14T11:40:41.461Zdaily1Edgen Stocken2026-05-14T11:40:41.461+00:00Healthcare Triangle Revenue Soars 166% After AI-Driven Acquisitionshttps://static.edgen.tech/news/images/healthcare-triangle-revenue-soars-166-after-ai-driven-acquisitions-20260514.pngHealthcare Triangle Revenue Soars 166% After AI-Driven Acquisitions https://edgen.beta.edgen.tech/news/post/cellectar-secures-140-million-to-advance-pivotal-cancer-therapy2026-05-14T11:40:17.671Zdaily1Edgen Stocken2026-05-14T11:40:17.671+00:00Cellectar secures $140 million to advance pivotal cancer therapyhttps://static.edgen.tech/news/images/cellectar-secures-140-million-to-advance-pivotal-cancer-therapy-20260514.pngCellectar secures $140 million to advance pivotal cancer therapy https://edgen.beta.edgen.tech/news/post/canada-goose-forecasts-weak-2027-sales-after-q4-revenue-beat2026-05-14T11:22:25.684Zdaily1Edgen Stocken2026-05-14T11:22:25.684+00:00Canada Goose forecasts weak 2027 sales after Q4 revenue beathttps://static.edgen.tech/news/images/canada-goose-forecasts-weak-2027-sales-after-q4-revenue-beat-20260514.pngCanada Goose forecasts weak 2027 sales after Q4 revenue beat https://edgen.beta.edgen.tech/news/post/brookfield-q1-distributable-earnings-climb-to-16-billion2026-05-14T11:19:58.708Zdaily1Edgen Stocken2026-05-14T11:19:58.708+00:00Brookfield Q1 distributable earnings climb to $1.6 billionhttps://static.edgen.tech/news/images/brookfield-q1-distributable-earnings-climb-to-16-billion-20260514.pngBrookfield Q1 distributable earnings climb to $1.6 billion https://edgen.beta.edgen.tech/news/post/nyc-mayor-fights-500m-western-union-deal-over-immigrant-fees2026-05-14T11:19:15.728Zdaily1Edgen Stocken2026-05-14T11:19:15.728+00:00NYC Mayor Fights $500M Western Union Deal Over Immigrant Feeshttps://static.edgen.tech/news/images/nyc-mayor-fights-500m-western-union-deal-over-immigrant-fees-20260514.pngNYC Mayor Fights $500M Western Union Deal Over Immigrant Fees https://edgen.beta.edgen.tech/news/post/hyperion-defi-rises-2-on-record-88m-q1-net-income-and-raised-guidance2026-05-14T11:18:23.951Zdaily1Edgen Stocken2026-05-14T11:18:23.951+00:00Hyperion DeFi Rises 2% on Record $8.8M Q1 Net Income and Raised Guidancehttps://static.edgen.tech/news/images/hyperion-defi-rises-2-on-record-88m-q1-net-income-and-raised-guidance-20260514.pngHyperion DeFi Rises 2% on Record $8.8M Q1 Net Income and Raised Guidance https://edgen.beta.edgen.tech/news/post/smic-q1-profit-misses-as-china-chip-push-squeezes-margins2026-05-14T11:17:16.292Zdaily1Edgen Stocken2026-05-14T11:17:16.292+00:00SMIC Q1 Profit Misses as China Chip Push Squeezes Marginshttps://static.edgen.tech/news/images/smic-q1-profit-misses-as-china-chip-push-squeezes-margins-20260514.pngSMIC Q1 Profit Misses as China Chip Push Squeezes Margins https://edgen.beta.edgen.tech/news/post/invivyd-loss-widens-to-41m-as-trial-costs-mount-despite-22-revenue-growth2026-05-14T11:12:31.680Zdaily1Edgen Stocken2026-05-14T11:12:31.680+00:00Invivyd loss widens to $41M as trial costs mount despite 22% revenue growthhttps://static.edgen.tech/news/images/invivyd-loss-widens-to-41m-as-trial-costs-mount-despite-22-revenue-growth-20260514.pngInvivyd loss widens to $41M as trial costs mount despite 22% revenue growth